IHM
ADVM

Iguana Healthcare Management’s Adverum Biotechnologies ADVM Stock Holding History

Iguana Healthcare Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.16M Hold
20,000
– – 0.76% 47
2017
Q4 		$700K Buy
+20,000
New +$658K 0.46% 55

Other funds holding ADVM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Iguana Healthcare Management's ADVM Position: Q1 2018 in Review

Iguana Healthcare Management held its Adverum Biotechnologies (ADVM) position steady in Q1 2018 at 20,000 shares worth $1.16M. The position accounts for 0.76% of the portfolio, ranked #47.

Iguana Healthcare Management first reported a position in ADVM in Q4 2017 and has held it in 2 quarters since. 96 funds tracked by Wall St. Rank hold ADVM as of Q1 2018.

  • Iguana Healthcare Management held 20,000 shares of Adverum Biotechnologies worth $1.16M as of Q1 2018.
  • Iguana Healthcare Management left its Adverum Biotechnologies share count unchanged in Q1 2018.
  • Adverum Biotechnologies made up 0.76% of Iguana Healthcare Management's portfolio in Q1 2018, its #47 holding.
  • Iguana Healthcare Management first reported a position in Adverum Biotechnologies in Q4 2017 and has held it in 2 quarters since.
  • 96 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.